Assenagon Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-72,234
Closed -$3.83M 1497
2021
Q3
$3.83M Buy
+72,234
New +$4.07M 0.01% 507
2018
Q1
Sell
-37,182
Closed -$1.18M 657
2017
Q4
$1.18M Buy
+37,182
New +$1.27M 0.01% 509

Other funds holding LMAT

Assenagon Asset Management's LMAT Position: Q4 2021 in Review

Assenagon Asset Management sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 72,234 shares — an estimated $3.83M sold.

Assenagon Asset Management first reported a position in LMAT in Q4 2017 and held it in 2 quarters. The position peaked at $3.83M in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Assenagon Asset Management reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 72,234 LeMaitre Vascular shares in Q4 2021, an estimated $3.83M.
  • Assenagon Asset Management first reported a position in LeMaitre Vascular in Q4 2017 and held it in 2 quarters.
  • Assenagon Asset Management's LeMaitre Vascular position peaked at $3.83M in Q3 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.